Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,338 warrant series at 1,059 companies. 777 in the money, 58 expiring in the next 30 days, 39 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series G unit warrants (price-protected, now $0.66) | $0.4167 | $14.8M | 424B3, Nov 14, 2025Dilution tabAs of Nov 13, 2026 | ||||||||
| Class A Ordinary Share Purchase Warrants (October 2025 Private Placement Ordinary Warrants) | $0.9740 | $14.7M | F-1, Nov 14, 2025Dilution tabAs of Nov 2, 2026 | ||||||||
| Placement Agent Warrants (August 2025 Private Placement) | $0.9740 | $14.7M | F-1/A, Oct 23, 2025Dilution tabAs of Nov 2, 2026 | ||||||||
| Placement Agent Warrants (March 26, 2026 Convertible Notes) | $0.9740 | $14.7M | 20-F, Aug 17, 2026Dilution tabAs of Nov 2, 2026 | ||||||||
| Placement Agent Warrants (March 31, 2026 Convertible Note) | $0.9740 | $14.7M | 20-F, Aug 17, 2026Dilution tabAs of Nov 2, 2026 | ||||||||
| Placement Agent Warrants (October 2025 Private Placement) | $0.9740 | $14.7M | F-1, Nov 14, 2025Dilution tabAs of Nov 2, 2026 | ||||||||
| Placement Agent Warrants (Series B Financing additional closing, March 26, 2026) | $0.9740 | $14.7M | 20-F, Aug 17, 2026Dilution tabAs of Nov 2, 2026 | ||||||||
| Placement Agent Warrants (Series B Financing initial closing, February 13, 2026) | $0.9740 | $14.7M | 20-F, Aug 17, 2026Dilution tabAs of Nov 2, 2026 | ||||||||
| Pre-Funded Warrants (August 2025 and October 2025 private placements, combined remaining balance) | $0.9740 | $14.7M | 20-F/A, Aug 21, 2026Dilution tabAs of Nov 2, 2026 | ||||||||
| Consultant warrant – 58 Concourse Partners LLC ($17.00, issued 2023-03-22) | $0.6141 | $14.7M | 10-Q, Aug 19, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| New Warrants (Credit Agreement lender warrants, $0.01, exp. July 2, 2035) | $0.7820 | $14.7M | 10-Q, Nov 4, 2026Dilution tabAs of Nov 4, 2026 | ||||||||
| PIPE Common Stock Warrants (January 2026 Private Placement) | $0.3316 | $14.6M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Public Warrants (ESLAW, assumed from TradeUP Acquisition Corp.) | $0.3316 | $14.6M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Cathedra assumed warrants (June 2026) | $1.36 | $14.4M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| February 2022 Warrants ($280.00) | $1.36 | $14.4M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| February 2022 Warrants ($350.00) | $1.36 | $14.4M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| February 2022 Warrants ($420.00) | $1.36 | $14.4M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| October 2025 Warrants (Armistice inducement warrants, $9.40) | $1.36 | $14.4M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| September 2026 PIPE Warrants ($3.50) | $1.36 | $14.4M | 10-Q, Nov 6, 2026Dilution tabAs of Nov 9, 2026 | ||||||||
| Broker Warrants (pre-Merger, B. Riley, $5.98) | $0.9126 | $14.4M | S-1, Jul 18, 2025Dilution tabAs of Nov 10, 2026 | ||||||||
| March 2025 Finder's Warrants - Canaccord ($4.00) | $0.9126 | $14.4M | S-1, Jul 18, 2025Dilution tabAs of Nov 10, 2026 | ||||||||
| March 2025 Finder's Warrants - Research Capital | $0.9126 | $14.4M | S-1, Jul 18, 2025Dilution tabAs of Nov 10, 2026 | ||||||||
| March 2025 Units Offering Warrants ($4.00) | $0.9126 | $14.4M | 424B3, Jul 2, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| March 2026 150% Warrants (Additional Closing, $1.88) | $0.9126 | $14.4M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| March 2026 150% Warrants (Initial Closing, $1.88) | $0.9126 | $14.4M | 424B3, Jul 2, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| March 2026 200% Warrants (Additional Closing, $2.50) | $0.9126 | $14.4M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| March 2026 200% Warrants (Initial Closing, $2.50) | $0.9126 | $14.4M | 424B3, Jul 2, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| March 2026 Pre-Funded Warrant (Additional Closing, Apr 16, 2026) | $0.9126 | $14.4M | 10-Q, Nov 10, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| March 2026 Pre-Funded Warrants (Initial Closing, Mar 12, 2026) | $0.9126 | $14.4M | 424B3, Jul 2, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Pre-funded warrants (Dec 16, 2025 Warrants Cancellation and Exchange Agreement) | $0.9126 | $14.4M | 424B3, Jul 2, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series C Offering Broker Warrants ($12.31) | $0.9126 | $14.4M | 424B3, Jul 2, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series C Warrants (Series C Financing, $24.62) | $0.9126 | $14.4M | 424B3, Jul 2, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| WaveDancer legacy warrants (assumed in Merger) | $0.9126 | $14.4M | 424B3, Jul 2, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| 2024 Series A Warrants (September 2024 inducement) | $2.85 | $14.3M | 10-Q, Aug 18, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Consultant warrants (May 2022 settlement, $82.50) | $2.85 | $14.3M | 10-K, Apr 15, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| December 2022 Common Warrants (amended July 2023, repriced to $2.75) | $2.85 | $14.3M | 424B3, Dec 19, 2025Dilution tabAs of Nov 13, 2026 | ||||||||
| December 2022 Common Warrants (unamended, original $11.50 strike) | $2.85 | $14.3M | 424B3, Dec 19, 2025Dilution tabAs of Nov 13, 2026 | ||||||||
| Exchange Warrants (October 2022 warrant exchange) | $2.85 | $14.3M | 424B3, Dec 19, 2025Dilution tabAs of Nov 13, 2026 | ||||||||
| July 2023 Common Warrants | $2.85 | $14.3M | 424B3, Dec 19, 2025Dilution tabAs of Nov 13, 2026 | ||||||||
| Series B Common Warrants (October 2022 public offering) | $2.85 | $14.3M | 424B3, Dec 19, 2025Dilution tabAs of Nov 13, 2026 | ||||||||
| Warrants with no expiration date (10-Q aggregate line) | $2.85 | $14.3M | 10-Q, Aug 18, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Avenue Capital 2024 Loan Warrants ($0.79) | $4.52 | $14.2M | 10-Q, Aug 6, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| Avenue Capital 2025 Amendment Warrants ($0.70) | $4.52 | $14.2M | 10-Q, Aug 6, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| December 13, 2023 Offering Warrants ($2.00, exp. 2028-12-13) | $4.52 | $14.2M | 10-Q, Aug 6, 2026Dilution tabAs of Oct 6, 2026 | ||||||||
| April 2024 Offering Agent | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 | ||||||||
| April 2024 Offering Investors | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 | ||||||||
| April 2025 Offering Agent | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 | ||||||||
| April 2026 Offering Agent | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 | ||||||||
| April 2026 Offering Investors | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 | ||||||||
| December 2025 Note Payable Extension | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 |
BLNEBeeline Holdings Inc.$0.4167Last price
Series G unit warrants (price-protected, now $0.66)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.8M
CRMNSkyline Builders Group Holding Limited Class A Ordinary Shares$0.9740Last price
Class A Ordinary Share Purchase Warrants (October 2025 Private Placement Ordinary Warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.7M
CRMNSkyline Builders Group Holding Limited Class A Ordinary Shares$0.9740Last price
Placement Agent Warrants (August 2025 Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.7M
CRMNSkyline Builders Group Holding Limited Class A Ordinary Shares$0.9740Last price
Placement Agent Warrants (March 26, 2026 Convertible Notes)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.7M
CRMNSkyline Builders Group Holding Limited Class A Ordinary Shares$0.9740Last price
Placement Agent Warrants (March 31, 2026 Convertible Note)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.7M
CRMNSkyline Builders Group Holding Limited Class A Ordinary Shares$0.9740Last price
Placement Agent Warrants (October 2025 Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.7M
CRMNSkyline Builders Group Holding Limited Class A Ordinary Shares$0.9740Last price
Placement Agent Warrants (Series B Financing additional closing, March 26, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.7M
CRMNSkyline Builders Group Holding Limited Class A Ordinary Shares$0.9740Last price
Placement Agent Warrants (Series B Financing initial closing, February 13, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.7M
CRMNSkyline Builders Group Holding Limited Class A Ordinary Shares$0.9740Last price
Pre-Funded Warrants (August 2025 and October 2025 private placements, combined remaining balance)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.7M
BEEMBeam Global$0.6141Last price
Consultant warrant – 58 Concourse Partners LLC ($17.00, issued 2023-03-22)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.7M
FTCIFTC Solar, Inc.$0.7820Last price
New Warrants (Credit Agreement lender warrants, $0.01, exp. July 2, 2035)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.7M
ESLAEstrella Immunopharma, Inc.$0.3316Last price
PIPE Common Stock Warrants (January 2026 Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.6M
ESLAEstrella Immunopharma, Inc.$0.3316Last price
Public Warrants (ESLAW, assumed from TradeUP Acquisition Corp.)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.6M
DRKDarkHorse Technologies Inc.$1.36Last price
Cathedra assumed warrants (June 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
DRKDarkHorse Technologies Inc.$1.36Last price
February 2022 Warrants ($280.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
DRKDarkHorse Technologies Inc.$1.36Last price
February 2022 Warrants ($350.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
DRKDarkHorse Technologies Inc.$1.36Last price
February 2022 Warrants ($420.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
DRKDarkHorse Technologies Inc.$1.36Last price
October 2025 Warrants (Armistice inducement warrants, $9.40)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
DRKDarkHorse Technologies Inc.$1.36Last price
September 2026 PIPE Warrants ($3.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
AIFFFirefly Neuroscience, Inc.$0.9126Last price
Broker Warrants (pre-Merger, B. Riley, $5.98)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
AIFFFirefly Neuroscience, Inc.$0.9126Last price
March 2025 Finder's Warrants - Canaccord ($4.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
AIFFFirefly Neuroscience, Inc.$0.9126Last price
March 2025 Finder's Warrants - Research Capital
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
AIFFFirefly Neuroscience, Inc.$0.9126Last price
March 2025 Units Offering Warrants ($4.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
AIFFFirefly Neuroscience, Inc.$0.9126Last price
March 2026 150% Warrants (Additional Closing, $1.88)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
AIFFFirefly Neuroscience, Inc.$0.9126Last price
March 2026 150% Warrants (Initial Closing, $1.88)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
AIFFFirefly Neuroscience, Inc.$0.9126Last price
March 2026 200% Warrants (Additional Closing, $2.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
AIFFFirefly Neuroscience, Inc.$0.9126Last price
March 2026 200% Warrants (Initial Closing, $2.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
AIFFFirefly Neuroscience, Inc.$0.9126Last price
March 2026 Pre-Funded Warrant (Additional Closing, Apr 16, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
AIFFFirefly Neuroscience, Inc.$0.9126Last price
March 2026 Pre-Funded Warrants (Initial Closing, Mar 12, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
AIFFFirefly Neuroscience, Inc.$0.9126Last price
Pre-funded warrants (Dec 16, 2025 Warrants Cancellation and Exchange Agreement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
AIFFFirefly Neuroscience, Inc.$0.9126Last price
Series C Offering Broker Warrants ($12.31)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
AIFFFirefly Neuroscience, Inc.$0.9126Last price
Series C Warrants (Series C Financing, $24.62)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
AIFFFirefly Neuroscience, Inc.$0.9126Last price
WaveDancer legacy warrants (assumed in Merger)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.4M
COSMCosmos Health Inc.$2.85Last price
2024 Series A Warrants (September 2024 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.3M
COSMCosmos Health Inc.$2.85Last price
Consultant warrants (May 2022 settlement, $82.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.3M
COSMCosmos Health Inc.$2.85Last price
December 2022 Common Warrants (amended July 2023, repriced to $2.75)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.3M
COSMCosmos Health Inc.$2.85Last price
December 2022 Common Warrants (unamended, original $11.50 strike)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.3M
COSMCosmos Health Inc.$2.85Last price
Exchange Warrants (October 2022 warrant exchange)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.3M
COSMCosmos Health Inc.$2.85Last price
July 2023 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.3M
COSMCosmos Health Inc.$2.85Last price
Series B Common Warrants (October 2022 public offering)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.3M
COSMCosmos Health Inc.$2.85Last price
Warrants with no expiration date (10-Q aggregate line)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.3M
CTSOCytosorbents Corporation$4.52Last price
Avenue Capital 2024 Loan Warrants ($0.79)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTSOCytosorbents Corporation$4.52Last price
Avenue Capital 2025 Amendment Warrants ($0.70)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTSOCytosorbents Corporation$4.52Last price
December 13, 2023 Offering Warrants ($2.00, exp. 2028-12-13)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
April 2024 Offering Agent
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
April 2024 Offering Investors
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
April 2025 Offering Agent
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
April 2026 Offering Agent
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
April 2026 Offering Investors
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
December 2025 Note Payable Extension
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 18, 2026.
Read from 2,082 dilution snapshots. 4,886 of 5,338 series state an exercise price and 3,367 an expiry date. 282 record when exercise begins; that count grows as companies are re-extracted. 624 series are left off because their figures could not be restated for a stock split. 19 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.